|
| 37389830 | Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia. | Blood Adv | 2024 |
| 37560812 | Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. | Haematologica | 2024 |
| 37839675 | Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. | Mod Pathol | 2024 |
| 38052038 | Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia. | Blood Adv | 2024 |
| 37683132 | Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. | JCO Oncol Pract | 2024 |
| 36951152 | Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm. | Haematologica | 2024 |
| 36332187 | Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings. | Blood | 2023 |
| 37483562 | Prediction of risk for myeloid malignancy in clonal hematopoiesis. | NEJM Evid | 2023 |
| 37995105 | Unraveling KMT2A-rearranged ALL. | Blood | 2023 |
| 37725576 | Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. | Clin Cancer Res | 2023 |
| 37451200 | Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia. | Leuk Res | 2023 |
| 37102976 | A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies. | Blood Cancer Discov | 2023 |
| 37432068 | Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials. | Blood Adv | 2023 |
| 37163357 | FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged â¿¥60 years. | Blood Adv | 2023 |
| 36752714 | Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic. | J Adolesc Young Adult Oncol | 2023 |
| 36655338 | Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial. | Cancer | 2023 |
| 36787235 | Exploring Influencing Factors of Anxiety Improvement Following Mindfulness-Based Music Therapy in Young Adults with Cancer. | J Music Ther | 2023 |
| 36609595 | Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. | Commun Biol | 2023 |
| 36577290 | Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantation. | Leuk Res | 2023 |
| 36508268 | Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia. | Blood Adv | 2023 |
| 36534523 | Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. | Clin Cancer Res | 2023 |
| 34348451 | Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study. | Haematologica | 2022 |
| 35609336 | The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug. | J Med Chem | 2022 |
| 35503981 | Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum. | Am Soc Clin Oncol Educ Book | 2022 |
| 36435843 | A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements. | Commun Biol | 2022 |
| 35949404 | The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study. | Open Forum Infect Dis | 2022 |
| 36394905 | A challenging choice: consolidation in Ph+ ALL. | Blood | 2022 |
| 34921959 | Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms. | Exp Hematol | 2022 |
| 35289704 | Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax. | Leuk Lymphoma | 2022 |
| 35015684 | BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes. | Blood Cancer Discov | 2022 |
| 35312041 | Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia. | Br J Haematol | 2022 |
| 34996739 | SOHO State of the Art Updates and Next Questions: Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future. | Clin Lymphoma Myeloma Leuk | 2022 |
| 35142153 | Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. | Haematologica | 2022 |
| 35081257 | Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy. | Blood Adv | 2022 |
| 34896280 | Exploring the Feasibility of a Mindfulness-Music Therapy Intervention to Improve Anxiety and Stress in Adolescents and Young Adults with Cancer. | J Pain Symptom Manage | 2022 |
| 34587239 | t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity. | Blood Adv | 2022 |
| 34610104 | Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials. | Blood Adv | 2022 |
| 34480712 | Resident-Reported Impact of a Novel Oncology Curriculum for Internal Medicine Residents. | J Cancer Educ | 2022 |
| 33237587 | Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. | Cancer | 2021 |
| 33621486 | Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms. | Cell Stem Cell | 2021 |
| 33926625 | Oral myeloid sarcoma as an uncommon manifestation of acute myeloid leukemia: A case series and review of the literature. | J Am Dent Assoc | 2021 |
| 33840625 | Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. | Transplant Cell Ther | 2021 |
| 33586600 | NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation. | Leuk Lymphoma | 2021 |
| 33837971 | Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction. | Am J Hematol | 2021 |
| 34889389 | Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy? | Hematology Am Soc Hematol Educ Program | 2021 |
| 34473244 | Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. | Blood Adv | 2021 |
| 34048999 | Triazole antifungal use for prophylaxis and treatment of invasive fungal diseases for patients receiving gilteritinib. | Leuk Res | 2021 |
| 33947777 | Clinical Reasoning: A 59-Year-Old Woman Presenting With Diplopia, Dysarthria, Right-Sided Weakness, and Encephalopathy. | Neurology | 2021 |
| 31004014 | Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study. | Haematologica | 2020 |
| 31837959 | Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial. | Lancet Haematol | 2020 |